< br > < b > Stock News < br > < span class = "section-news" > 1. Shell (SHEL. N) wins appeal in latest Dutch emissions ruling. < br > < span class = "section-news" > 2. AstraZeneca (AZN. O) again raises its revenue and profit forecast for this year. < br > < span class = "section-news" > 3. Boeing (BA. N) wins order for 80 737 Max aircraft from Avia Solutions. < br > < span class = "section-news" > 4. According to the official website of CDE, Novartis Pharmaceuticals (NVS. N) 's atracentan hydrochloride tablets are to be included in the priority review, and the indication is to reduce proteinuria in adult patients with primary immunoglobulin A nephropathy (IgAN) at risk of disease progression. < br > < span class = "section-news" > 5. Johnson & Johnson (JNJ. N) nicalizumab injection is to be included in the priority review, which is suitable for the treatment of autoantibody-positive systemic myasthenia gravis. < br > < span class = "section-news" > 6. Morgan Stanley raised its price target on Dell (DELL. N) to $154 from $136 and maintained its "overweight" rating, citing an increase in sales of the company's artificial intelligence servers. < br > < span class = "section-news" > 7. Tiger Securities (TIGR. O) reported Q3 results, revenue of $101 million, an increase of 15.6% month-on-month, an increase of 44.1% year-on-year, a record high; non-GAAP net profit attributable to the parent company was $20.10 million, an increase of 286.5% month-on-month, an increase of 25.6% year-on-year. < br > < span class = "section-news" > 8. Huya (HUYA. N): In Q3 of 24, the company's total revenue reached 1.54 billion yuan, and the net profit attributable to the parent company was 78 million yuan. Among them, the revenue from game-related services, advertising and other businesses increased by 209.3% year-on-year to 410 million yuan.